IntegraGen: 2024 Annual Results Apr 29, 2025 12:00PM
IntegraGen: 2024 Half-Year Results - Sales up 6% on a Like-for-Like Basis (Excluding SeqOIA) and Profitability Maintained Oct 17, 2024 12:29PM
IntegraGen: First-Half 2024 Sales of €4.5m, up 6% on the Scope Excluding SeqOIA and Cash Position of €2.8m Jul 18, 2024 12:44PM
IntegraGen: Annual Results 2023 - Positive EBITDA Reflecting Tight Cost Control Apr 18, 2024 12:00PM
IntegraGen Reports €11.8M Revenues for 2023 Jan 16, 2024 11:45AM


Jul 13, 2023 01:30AM IntegraGen Reports €5.6m in Revenues for H1 2023 Representing 13% Decrease Compared to H1 2022 and a Cash Position of €4.3m
Jan 13, 2023 01:30AM IntegraGen Reports €12.6m in Revenues for 2022 Representing 16% Growth Compared to 2021 and a Cash Position of €4.5m
Oct 18, 2022 01:30AM Results for the First Half of 2022 - IntegraGen Reports Strong Revenues Growth of 35% With Profitability Improvement
Jul 13, 2022 01:30AM IntegraGen reports 6.4 M€ in revenues for the first half of 2022 representing 34% growth compared to H1 2021. Cash position of 4.5 M€.
Apr 29, 2022 12:58PM IntegraGen Reports 2021 Annual Results With a Strong Growth of 20% in Revenue From Current Operations and a Significant Profitability Improvement
Oct 8, 2021 01:30AM IntegraGen Reports Results for 1st Half of 2021
Jul 16, 2021 01:30AM IntegraGen Reports Sales of 4.8 M€ for the First Half of 2021, a 2% Increase Versus 2020, and a Cash Position of 4.3 M€